Predictive Oncology
EAGAN, MN · Artificial Intelligence, Biotechnology, Blockchain · 20 employees
Predictive Oncology is on a mission to transform oncology drug discovery and drive the development of more effective cancer therapies. By leveraging machine learning, scientific expertise, and biologics, we work to increase the probability of success and advance drug compounds with greater precision and confidence.
Funding history
- Funding Round — $173.3M — Oct 2025
- Funding Round — $50.8M — Oct 2025
- Series seed — $413K — Sep 2025
- Funding Round — $2.2M — Aug 2024
- Funding Round — $2.3M — Jun 2022
Recent signals
- May 15, 2026: Axe Compute Inc. Appoints Kyle Okamoto as President and Jeremy Yaukey-Witter as Chief Financial Officer
- Feb 09, 2026: Axe Compute Appoints Christopher Miglino as Chief Executive Officer
- Oct 22, 2025: Raised $173.3M
- Oct 22, 2025: Raised $50.8M
- Oct 14, 2025: Predictive Oncology Appoints Thomas McLaughlin as Chief Investment Officer and Sara Turken as General Counsel
- Sep 08, 2025: Raised $413K in Series seed
- Feb 10, 2025: Predictive Oncology Partners with Tecan Group Ltd. for High-Throughput Drug Screening Expansion
- Dec 03, 2024: Launched Predictive Oncology Inc. evaluates strategic alternatives to enhance shareholder value as of December 3, 2024.
See plans & pricing → Track Predictive Oncology’s funding, hiring, and signals — with verified contacts — on Fundz.